Development of AAV-GBA1 Gene Replacement Therapy via Single-IV-Delivery with a Blood Brain Barrier Penetrant AAV Capsid

被引：0
|
作者：
Chung, Charlotte [1 ]
Retzlaff, Cassie [1 ]
Thompson, Jeff [1 ]
Bloedel, Alexis [1 ]
Bruce, Amy [1 ]
Ecker, Abigail [1 ]
Clement, Joseph [1 ]
Knoll, Elisabeth R. [1 ]
Ezell, Brian C. [1 ]
Hoffman, Brett [1 ]
Knox, Tatiana [1 ]
Nonnenmacher, Mathieu E. [1 ]
Moyer, Tyler [1 ]
Lin, Jing [1 ]
Grant, Kyle [1 ]
Paranjpe, Maneesha [1 ]
Pande, Nilesh [1 ]
Johnson, Amy [1 ]
Yao, Johnny [1 ]
Sadhu, Chanchal [1 ]
Carter, Todd A. [1 ]
机构：
[1] Voyager Therapeut, Cambridge, MA USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
695
引用
收藏
页码：347 / 347
页数：1
相关论文
共 32 条
  • [1] Development of AAV-GBA1 Gene Replacement Therapy for IV Delivery via Blood Brain Barrier Penetrant AAV Capsid
    Chung, Charlotte
    Murlidharan, Giri
    Jagtap, Smita
    Adeluyi, Adewale
    Knoll, Elisabeth
    Ecker, Abigail
    Ezell, Brian
    Athanasopoulos, Tatiana
    Hoffman, Brett
    Knox, Tatiana
    Tocci, Jenna
    Peterson, Emalee
    Sayed-Zahid, Ambreen
    Paranjpe, Maneesha
    Grant, Kyle
    Bales, Kelly
    Carter, Todd
    MOLECULAR THERAPY, 2022, 30 (04) : 268 - 268
  • [2] Development of CNS-directed GBA1 gene replacement therapy for IV delivery via Blood Brain Barrier Penetrant AAV Capsid
    Murlidharan, G.
    Jagtap, S.
    Adeluyi, A.
    Knoll, E.
    Ecker, A.
    Ezell, B.
    Athanasopoulos, T.
    Pande, N.
    Tyson, K.
    Laguna-Torres, J.
    Jordan, A.
    Hoffman, B.
    Knox, T.
    Tocci, J.
    Peterson, E.
    Chung, C.
    Kelly, M.
    Sayed-Zahid, A.
    Paranjpe, M.
    Zhou, R.
    Grant, K.
    Carter, T.
    Bales, K.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A53 - A54
  • [3] AAV-GBA1 gene therapy for Parkinson's disease
    Glajch, K. E.
    Apicco, D. J.
    Chen, Y.
    Campbell, A. C.
    Hronowski, X.
    Hirst, W. D.
    HUMAN GENE THERAPY, 2018, 29 (12) : A86 - A86
  • [4] Process and Formulation Development for a Novel Blood-Brain Barrier Penetrant AAV Capsid
    Kim, Taeho
    Xie, Zelong
    Ghazvini, Saba
    Padilla, Jada
    Ward, Alex M.
    Tiffany, Matthew R.
    Ojala, David
    Patel, Nikul
    Chikere, Anthony
    Ramsey, Phillip
    Yadav, Sandeep
    MOLECULAR THERAPY, 2024, 32 (04) : 504 - 504
  • [5] Systemic Gene Therapy for Brain Malignancy Using Blood-Brain-Barrier-Penetrant AAV Vectors
    Yao, Yizheng
    Wan, Jie
    Wang, Jun
    Liu, Yi
    Qu, Yuan
    Wang, Kaikai
    Chiocca, E. A.
    Bei, Fengfeng
    MOLECULAR THERAPY, 2022, 30 (04) : 163 - 164
  • [6] A blood-brain barrier-penetrant AAV gene therapy improves neurological function in symptomatic mucolipidosis IV mice
    Sangster, Madison L.
    Bishop, Martha M.
    Yao, Yizheng
    Feitor, Jessica F.
    Shahriar, Sanjid
    Miller, Maxwell E.
    Chekuri, Anil K.
    Budnik, Bogdan
    Bei, Fengfeng
    Grishchuk, Yulia
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (02)
  • [7] Cell Specific Transduction of a Vectorized Anti-Tau Antibody Using IV Dosing of a Blood Brain Barrier Penetrant AAV Capsid in Mice
    Liu, Wencheng
    Murlidharan, Giridhar
    Shu, Yanqun
    Paranjpe, Maneesha
    Chung, Charlotte
    Ren, Xiao-Qin
    Wang, Xin
    Grant, Kyle
    Johnson, Brianna
    Hameedi, Usman
    Felix-Ortiz, Ada
    Goulet, Martin
    Hou, Jay
    Sah, Dinah
    Paul, Steve
    Carter, Todd
    MOLECULAR THERAPY, 2019, 27 (04) : 19 - 19
  • [8] Transduction of Various Fragment Forms of Vectorized Anti-Tau Antibodies Using IV Dosing of a Blood Brain Barrier Penetrant AAV Capsid in Mice
    Liu, Wencheng
    Murlidharan, Giridhar
    Shu, Yanqun
    Van Heteren, Jane
    Paranjpe, Maneesha
    Chung, Charlotte
    Ren, Xiao-Qin
    Grant, Kyle
    Johnson, Brianna
    Hameedi, Usman
    Sah, Dinah
    Khwaja, Omar
    Bales, Kelly
    Paul, Steve
    Hou, Jay
    Carter, Todd
    MOLECULAR THERAPY, 2020, 28 (04) : 316 - 317
  • [9] AAV gene delivery of an anti-Tau antibody using a novel blood brain barrier penetrant capsid in wild type and P301S tauopathy mice
    Carter, T. A.
    Liu, W.
    Murlidharan, G.
    Shu, Y.
    Paranjpe, M.
    Huang, C.
    Mazzarelli, A.
    Pechan, P.
    Horowitz, E.
    Chen, Q.
    Hou, J.
    Sah, D.
    Paul, S.
    HUMAN GENE THERAPY, 2017, 28 (12) : A80 - A80
  • [10] Development of an AAV-GBA Gene Therapy for the Treatment of Type 1 Gaucher Disease
    Cheng, Ting-Wen
    Souza, David
    Tabet, Ricardos
    Wright, Katherine
    Brodfuehrer, Joanne
    Keyes, Lisa
    Rao-Dayton, Sheila
    Lewis, Patricia
    Sievers, Annette
    McCarty, Douglas M.
    Somanathan, Suryanarayan
    Pan, Clark
    Bell, Robert D.
    MOLECULAR THERAPY, 2021, 29 (04) : 251 - 251
1234